Who Wants To Buy Sanofi SA (ADR) (NYSE:SNY)’s Older Drugs Division?

Boston, MA 05/01/2014 (wallstreetpr) – Sanofi SA (ADR) (NYSE:SNY) is on the verge of selling its older drugs portfolio. The portfolio is reported to be made up of drugs targeted at the treatment of cardio-metabolic conditions and high blood pressure. The drug portfolio fetches about $3.7 billion in annual revenue, according to people with insider knowledge. […]

Sanofi SA (ADR) (NYSE:SNY) Prefers Small Deals Over Mega Acquisitions

Boston, MA 04/29/2014 (wallstreetpr) – On Tuesday, Sanofi SA (ADR) (NYSE:SNY)‘s Chief Executive Officer, Christopher Viehbacher, reiterated that the French drug maker will continue to concentrate on its targeted smaller acquisitions, even as the pharmaceutical sector is hitting several megadeals. Focus On Growth Areas The comment of Mr. Viehbacher comes at a time when a day […]

Merger Talks Between AstraZeneca plc (ADR) (NYSE:AZN) And Pfizer Inc. (PFE) Now Dormant

Boston, MA 04/21/2014 (wallstreetpr) – The reported merger talks between AstraZeneca plc (ADR) (NYSE:AZN) And Pfizer Inc. (NYSE:PFE) occurred several months ago but are currently dormant. In other words, the two drug companies are not currently in any tie-up talks.  However, high-placed sources revealed that there were informal talks for a tie-up during which Pfizer reportedly […]

Abbott Laboratories (NYSE:ABT)’S Spinoff Abbivie Urged U.S. Court To Review Ruling In HIV Drug Trail

Boston, MA 04/21/2014 (wallstreetpr) – A spinoff of Abbott Laboratories (NYSE:ABT) insisted on a federal appeals court in San Francisco to rethink its decision in the case against Glaxo SmithKline plc (ADR) (NYSE:GSK). On Thursday, AbbVie Inc (NYSE:ABBV) urged the 9th U.S. Circuit Court of Appeals to revisit a preliminary three judge ruling according to which […]

Pfizer Inc (NYSE:PFE) Among The Ten To Collaborate With The U.S. Government In Combating America’s Most Prevalent Diseases

Boston, MA 02/06/2014 (wallstreetpr) – Pfizer Inc (NYSE:PFE) is to work with the U.S. government to develop new treatments for some of the most prevalent diseases among Americans. In a $230 million project the government is trying to identify new cure for Alzheimer’s, diabetes, lupus and arthritis. In accordance with the practice of ‘groundbreaking’ at […]

Stock Update: Alpha Natural Resources (NYSE:ANR); Johnson & Johnson (NYSE:JNJ) And Suncor Energy Inc. (USA) (NYSE:SU)

Boston, MA 02/05/2014 (wallstreetpr) – Alpha Natural Resources (NYSE:ANR), declared in a press release that four of its associateoperations have been admiredfor protecting the environment. Alpha has received the honors from two departments namely, West Virginia Department of Environmental Protection and the other being West Virginia Coal Association for its exceptional contribution towards reclamation, reforestation […]

New Fabry Drug Report Drags Amicus Down

Boston, MA 02/19/2013 (wallstreetpr) – Amicus Therapeutics, Inc. (NASDAQ:FOLD) had been working on a drug called migalastat. This drug was being developed for the treatment of a rare genetic disorder named Fabry disease which is caused when body cells buildup a certain type of fat. This fat is highly detrimental to the health in that […]